Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr 14;386(15):1463-1464.
doi: 10.1056/NEJMe2202160. Epub 2022 Feb 16.

The Potential of Intentional Drug Development

Eric J Rubin, Lindsey R Baden
Editorial

The Potential of Intentional Drug Development

Eric J Rubin et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Heil EL, Kottilil S. The Goldilocks time for remdesivir — is any indication just right? N Engl J Med 2022;386:385-387. - PMC - PubMed
    1. Hammond J, Leister-Tebbe H, Gardner A, et al.. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2118542. - DOI - PMC - PubMed
    1. Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med 2022;386:509-520. - PMC - PubMed
    1. Takashita E, Kinoshita N, Yamayoshi S, et al. Efficacy of antibodies and antiviral drugs against Covid-19 omicron variant. N Engl J Med. DOI: 10.1056/NEJMc2119407. - DOI - PMC - PubMed
    1. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 — final report. N Engl J Med 2020;383:1813-1826. - PMC - PubMed

Publication types